The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation

被引:99
作者
Wang, SW
Leonard, SS
Ye, JP
Ding, M
Shi, XL [1 ]
机构
[1] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV 26505 USA
[2] W Virginia Univ, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2000年 / 279卷 / 03期
关键词
Cr(VI) carcinogenesis; reactive oxygen species;
D O I
10.1152/ajpcell.2000.279.3.C868
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study investigates whether reactive oxygen species (ROS) are involved in p53 activation, and if they are, which species is responsible for the activation. Our hypothesis is that hydroxyl radical (. OH) functions as a messenger for the activation of this tumor suppressor protein. Human lung epithelial cells (A549) were used to test this hypothesis. Cr(VI) was employed as the source of ROS due to its ability to generate a whole spectrum of ROS inside the cell. Cr(VI) is able to activate p53 by increasing the protein levels and enhancing both the DNA binding activity and transactivation ability of the protein. Increased cellular levels of superoxide radicals (O-2(-).), hydrogen peroxide (H2O2), and . OH radicals were detected on the addition of Cr(VI) to the cells. Superoxide dismutase, by enhancing the production of H2O2 from O-2(-). radicals, increased p53 activity. Catalase, an H2O2 scavenger, eliminated . OH radical generation and inhibited p53 activation. Sodium formate and aspirin, . OH radical scavengers, also suppressed p53 activation. Deferoxamine, a metal chelator, inhibited p53 activation by chelating Cr(V) to make it incapable of generating radicals from H2O2. NADPH, which accelerated the one-electron reduction of Cr(VI) to Cr(V) and increased . OH radical generation, dramatically enhanced p53 activation. Thus . OH radical generated from Cr(VI) reduction in A549 cells is responsible for Cr(VI)-induced p53 activation.
引用
收藏
页码:C868 / C875
页数:8
相关论文
共 49 条
[1]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[2]  
CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253
[3]  
CONNETT PH, 1983, STRUCT BOND, V54, P93
[4]   GENOTOXICITY OF CHROMIUM COMPOUNDS - A REVIEW [J].
DEFLORA, S ;
BAGNASCO, M ;
SERRA, D ;
ZANACCHI, P .
MUTATION RESEARCH, 1990, 238 (02) :99-172
[5]  
DEFLORA S, 1989, LIFE CHEM REPORTS, V7, P169
[6]   Exposure to chromium dust from homes in a chromium surveillance project [J].
Freeman, NCG ;
Stern, AH ;
Lioy, PJ .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1997, 52 (03) :213-219
[7]  
FRITSCHE M, 1993, ONCOGENE, V8, P307
[8]  
GHOSH P, 1994, CANCER RES, V54, P2969
[9]   p53 in growth control and neoplasia [J].
Gottlieb, TM ;
Oren, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :77-102
[10]   HYPOXIA INDUCES ACCUMULATION OF P53 PROTEIN, BUT ACTIVATION OF A G(1)-PHASE CHECKPOINT BY LOW-OXYGEN CONDITIONS IS INDEPENDENT OF P53 STATUS [J].
GRAEBER, TG ;
PETERSON, JF ;
TSAI, M ;
MONICA, K ;
FORNACE, AJ ;
GIACCIA, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :6264-6277